Z

Zomedica Corp
AMEX:ZOM

Watchlist Manager
Zomedica Corp
AMEX:ZOM
Watchlist
Price: 0.055 USD Market Closed
Market Cap: 53.9m USD

Intrinsic Value

ZOM's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one ZOM stock under the Base Case scenario is 0.171 USD. Compared to the current market price of 0.055 USD, Zomedica Corp is Undervalued by 68%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ZOM Intrinsic Value
0.171 USD
Undervaluation 68%
Intrinsic Value
Price
Z
Worst Case
Base Case
Best Case
Compare ZOM to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ZOM?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Zomedica Corp
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Zomedica Corp

Current Assets 87.3m
Cash & Short-Term Investments 76.9m
Receivables 2.4m
Other Current Assets 8m
Non-Current Assets 126.8m
Long-Term Investments 966k
PP&E 27.4m
Intangibles 97.2m
Other Non-Current Assets 1.3m
Efficiency

Free Cash Flow Analysis
Zomedica Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Zomedica Corp

Revenue
26.7m USD
Cost of Revenue
-8.1m USD
Gross Profit
18.6m USD
Operating Expenses
-56.9m USD
Operating Income
-38.3m USD
Other Expenses
-23.9m USD
Net Income
-62.2m USD
Fundamental Scores

ZOM Profitability Score
Profitability Due Diligence

Zomedica Corp's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
25/100
Profitability
Score

Zomedica Corp's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

ZOM Solvency Score
Solvency Due Diligence

Zomedica Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Zomedica Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ZOM Price Targets Summary
Zomedica Corp

Wall Street analysts forecast ZOM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZOM is 0.255 USD with a low forecast of 0.253 USD and a high forecast of 0.263 USD.

Lowest
Price Target
0.253 USD
359% Upside
Average
Price Target
0.255 USD
364% Upside
Highest
Price Target
0.263 USD
377% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Zomedica Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for ZOM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ZOM Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ZOM stock?

The intrinsic value of one ZOM stock under the Base Case scenario is 0.171 USD.

Is ZOM stock undervalued or overvalued?

Compared to the current market price of 0.055 USD, Zomedica Corp is Undervalued by 68%.

Back to Top